Skip to main content
. 2013 Jul-Sep;4(3):151–159. doi: 10.4103/2231-4040.116785

Figure 3.

Figure 3

Comparative in vitro drug release profile of optimized formulation (F17) and marketed formulation of clobazam. Data are represented as mean ± SD (n= 3)